Novartis AG is 188.3x more valuable than Tyra Biosciences, Inc. by market capitalization ($283.13 B vs $1.50 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TYRA | NVS |
|---|---|---|
| Market cap | $1.50 B | $283.13 B |
| US-listed rank | #2316 | #47 |
| Net income (latest FY) | -$119.95M | - |
| SEC filings | 396 | 947 |
Novartis AG is 188.3x more valuable than Tyra Biosciences, Inc. by market capitalization ($283.13 B vs $1.50 B).
Full pages: Tyra Biosciences, Inc. and Novartis AG, or browse the full rankings.